Jason Alger, Chief Accounting Officer at Health Catalyst, Inc. (HCAT), sold 461 shares at $25.14 ($12K) on 2022-03-07, disclosed to the SEC on 2022-03-09.
Scheduled sale ($12k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HCAT | SELL | 2024-06-14 | $19K | — | Filing → |
| HCAT | SELL | 2023-12-07 | $16K | — | Filing → |
| HCAT | SELL | 2023-09-06 | $26K | — | Filing → |